Revvity Inc vs BlackRock TCP Capital Corp — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while BlackRock TCP Capital Corp trades at $3.24 (market cap $270.17M). The key difference: Revvity Inc is far larger — about 43.9× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays the higher dividend (26.09%). Which is the better fit depends on your goals.
| RVTY | TCPC | |
|---|---|---|
Market Cap | $11.87B | $270.17M |
Sector | Technology | Financials |
52-Week High | $117.75 | $7.64 |
52-Week Low | $82.26 | $3.14 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | 26.09% |
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →